We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Excessive Platelet Sterilization Potentially Dangerous

By LabMedica International staff writers
Posted on 22 Jun 2014
Chemical processes used to sterilize blood products could lead to serious health issues in transfusion recipients, according to a new study.

Researchers at Linköping University (Sweden), Université Laval (Québec, Canada), and other institutions documented the effects of pathogen reduction (PR) systems on microRNA and mRNA levels in platelets stored in the blood bank, and assessed their impact on platelet activation and function. The researchers compared the two standard PR methods, gamma irradiation alone or irradiation in combination with chemical substances that inactivate pathogenic agents by cross-linking to their nucleic acids (DNA and RNA).

The researchers found that unlike platelets subjected to gamma irradiation or stored in additive solution, the ones that were treated by the two PR systems available on the market, Intercept and Mirasol, aggregated badly, which worsened wound healing. Intercept also eradicated the nucleic acids of the platelets, causing them to become overactive and reduced in volume. Gamma radiation, on the other hand, had no damaging effects on the blood platelets. PR neither affected platelet microRNA synthesis or function, nor induced cross-linking of microRNA-sized endogenous platelet RNA species. The study was published early online on April 21, 2014, in Platelets.

“The processes that are used target the genetic material of pathogenic organisms; they were developed more than 20 years ago, before we understood the importance of the genetic material contained in platelets,” said corresponding author Patrick Provost, MD, of Université Laval. “These treatments activate blood platelets, triggering the release of RNA. The platelets end up depleted of RNA, so once transfused, they're unable to do what they normally would.”

“The problem is also that the blood platelets have nucleic acids that are very important for their wound healing abilities and communication with other cells,” added lead author clinical biochemist Abdimajid Osman, PhD, a researcher in Linköping University. “If they are eradicated it can damage the blood cells and lead to more severe bleeding for the patient. Our recommendation to blood centers is not to use any of the substances, only irradiation treatment.”

The function of platelets goes far beyond their role in blood coagulation and wound healing. They contain up to a third of the human genome in the form of ribonucleic acid (RNA), allowing them to synthesize over 1,000 proteins essential to the normal functioning of the human body. In contrast to other donated blood products, blood platelets must be stored at room temperature as they do not tolerate the cold. This entails a risk that pathogens such as bacteria and viruses develop and follow the platelets into the patient’s blood system. The consequence can be blood poisoning, in the worst case leading to death.

Related Links:
Linköping University
Université Laval

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Alcohol Testing Device
Dräger Alcotest 7000

Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more